PeptideDB

Oxychlororaphine 550-89-0

Oxychlororaphine 550-89-0

CAS No.: 550-89-0

Oxychloroaphine can be extracted from Panthesia agglomerans, which occurs naturally in soil. Oxychloroaphine displays a
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Oxychloroaphine can be extracted from Panthesia agglomerans, which occurs naturally in soil. Oxychloroaphine displays a broad-spectrum antifungal activity. Oxychloroaphine has concentration-dependent cytotoxic effect, leading to apoptosis. Oxychloroaphine may be utilized in cancer research.

Physicochemical Properties


Molecular Formula C13H9N3O
Molecular Weight 223.23
Exact Mass 223.075
CAS # 550-89-0
PubChem CID 120282
Appearance Light yellow to brown solid powder
Density 1.371g/cm3
Boiling Point 526.1ºC at 760 mmHg
Melting Point 242ºC
Flash Point 272ºC
Index of Refraction 1.76
LogP 2.582
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 3
Rotatable Bond Count 1
Heavy Atom Count 17
Complexity 307
Defined Atom Stereocenter Count 0
InChi Key KPZYYKDXZKFBQU-UHFFFAOYSA-N
InChi Code

InChI=1S/C13H9N3O/c14-13(17)8-4-3-7-11-12(8)16-10-6-2-1-5-9(10)15-11/h1-7H,(H2,14,17)
Chemical Name

phenazine-1-carboxamide
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


ln Vitro Oxychloroaphine (1-256 μM; 24 h) induces damage to cell membranes, increasing apoptosis and lactate dehydrogenase leakage, as well as increasing the formation of cytochrome c protein. The IC50 values for cytotoxic agents against A549, HeLa, and SW480 cancer cell lines range from 32 to 40 μM[2]. Cycle arrest at G1 phase and induction of sub-G phase are caused by oxychloroaphine (32 μM; A549 and SW480 cells) [2]. After 48 hours, oxychloroaphine (A549 cells) causes the proapoptotic protein caspase-3 to become activated, which in turn causes the cleavage of PARP[2]. This results in the downregulation of the antiapoptotic Bcl-2 protein.
Cell Assay Cell Viability Assay[2]
Cell Types: A549, HeLa, and SW480 cancer cell lines
Tested Concentrations: 1, 2, 4, 8, 16, 32, 64, 128, and 256 μM
Incubation Duration: 24 hrs (hours)
Experimental Results: Inhibited cell proliferative in a dose-dependent manner.
References

[1]. Comparative metabolomics and transcriptomics analyses provide insights into the high-yield mechanism of phenazines biosynthesis in Pseudomonas chlororaphis GP72. J Appl Microbiol. 2022 Nov;133(5):2790-2801.

[2]. Isolation of Bioactive Phenazine-1-Carboxamide from the Soil Bacterium Pantoea agglomerans and Study of Its Anticancer Potency on Different Cancer Cell Lines. J AOAC Int. 2016 Sep;99(5):1233-9.

Additional Infomation Phenazine-1-carboxamide is an aromatic amide that is phenazine substituted at C-1 with a carbamoyl group. It is a member of phenazines, an aromatic amide and a monocarboxylic acid amide.
Phenazine-1-carboxamide has been reported in Streptomyces with data available.

Solubility Data


Solubility (In Vitro) DMSO : 10 mg/mL (44.80 mM)
Solubility (In Vivo) Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution 50 μL Tween 80 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO 400 μLPEG300 50 μL Tween 80 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO 100 μLPEG300 200 μL castor oil 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol 100 μL Cremophor 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH 400 μLPEG300 50 μL Tween 80 450 μL Saline)

Oral Formulations Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders

Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 4.4797 mL 22.3984 mL 44.7968 mL
5 mM 0.8959 mL 4.4797 mL 8.9594 mL
10 mM 0.4480 mL 2.2398 mL 4.4797 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.